Literature DB >> 2045686

Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction.

G Zambruno1, L Mori, A Marconi, N Mongiardo, B De Rienzo, U Bertazzoni, A Giannetti.   

Abstract

Langerhans cells (LC) are bone marrow-derived, HLA-DR+, CD1a+, dendritic antigen-presenting cells found in stratified squamous epithelia. Within resident epidermal cells (EC), LC are the only cells expressing the CD4 antigen and are, therefore, a possible target for human immunodeficiency virus (HIV) infection. To date, conflicting results have been reported on the in vivo infection of LC by HIV. The aim of the present study was to investigate the presence of HIV-1 proviral DNA in epidermal LC of HIV-1-infected patients. EC suspensions were prepared from clinically normal skin of nine seropositive patients. Purified LC and LC-depleted EC were obtained by immunomagnetic separation and analyzed for the presence of HIV-1 proviral DNA by the polymerase chain reaction using primer pairs from different conserved regions (env and gag) of the HIV-1 genome. HIV-1 proviral DNA was detected in LC from seven of nine patients. LC-depleted EC fractions from the same nine patients were all negative, with the exception of one case. Altogether these results demonstrate that epidermal LC are infected by HIV-1 and constitute the only resident cell type in the epidermis harboring the virus. Further studies are, however, needed to demonstrate HIV replication in LC and to elucidate the functional role of LC in this infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045686     DOI: 10.1111/1523-1747.ep12476469

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  18 in total

1.  Regulation of primary HIV-1 isolate replication in dendritic cells.

Authors:  T H J MacDougall; R J Shattock; C Madsen; B M Chain; D R Katz
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection.

Authors:  M Sala; G Zambruno; J P Vartanian; A Marconi; U Bertazzoni; S Wain-Hobson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 3.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

Review 4.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 5.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 6.  Roles of autophagy in HIV infection.

Authors:  Christina Dinkins; Manohar Pilli; John H Kehrl
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.

Authors:  D I Gabrilovich; G M Woods; S Patterson; J J Harvey; S C Knight
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

9.  Epidermal and splenic antigen-presenting cell function in a retrovirally induced murine immunodeficiency syndrome (MAIDS).

Authors:  A Cerny; S Izui; J H Saurat; F A Waldvogel; H C Morse; C Hauser
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation.

Authors:  Y Tsunetsugu-Yokota; K Akagawa; H Kimoto; K Suzuki; M Iwasaki; S Yasuda; G Häusser; C Hultgren; A Meyerhans; T Takemori
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.